Top

Published in:

01-12-2020 | Antiarrhythmic Drugs | Original Article

Cryoballoon versus radiofrequency ablation for paroxysmal atrial fibrillation in hemodialysis patients

Authors: Tomomasa Takamiya, Junichi Nitta, Osamu Inaba, Akira Sato, Yukihiro Inamura, Nobutaka Kato, Kazuya Murata, Takashi Ikenouchi, Toshikazu Kono, Giichi Nitta, Yutaka Matsumura, Yoshihide Takahashi, Masahiko Goya, Tetsuo Sasano

Published in: Heart and Vessels | Issue 12/2020

Abstract

Introduction

Little evidence exists regarding cryoballoon ablation (CBA) of paroxysmal atrial fibrillation (PAF) in hemodialysis (HD) patients. We compared CBA and radiofrequency ablation (RFA) of PAF in HD patients, referring to CBA of PAF in non-HD patients.

Methods and results

This historical cohort study examined 88 patients who underwent catheter ablation of PAF, including 21 HD patients with a second-generation 28-mm cryoballoon (CB-HD group), 17 HD patients with a non-force-sensing radiofrequency catheter (RF-HD group), and 50 non-HD patients with a cryoballoon (CB-non-HD group). Pulmonary vein (PV) isolation alone aside from cavotricuspid isthmus ablation was performed in 14 (67%) in the CB-HD group, 12 (71%) in the RF-HD group, and 36 (72%) in the CB-non-HD group (P = 0.95), without isoproterenol-induced non-PV triggers. Non-PV trigger ablation was added to the other patients. The Kaplan–Meier estimated 1-year freedom from atrial tachyarrhythmia recurrence without antiarrhythmic drugs after a single procedure was 76%, 59%, and, 92% in the CB-HD, RF-HD, and CB-non-HD groups, respectively (P = 0.002). The mean procedure time was shorter in the CB-HD group than in the RF-HD group (127 vs. 199 min; P < 0.001). In the second procedure, the median number of reconnected pulmonary veins was 0.5 in the CB-HD group versus 2.0 in the RF-HD group (P = 0.17).

Conclusion

For PAF in HD patients, CBA showed a comparable single-procedure efficacy to that of RFA with a short procedure time. CBA may be a reasonable initial procedure for HD patients suffering from symptomatic PAF.

Alonso A, Lopez FL, Matsushita K, Loehr LR, Agarwal SK, Chen LY, Soliman EZ, Astor BC, Coresh J (2011) Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 123:2946–2953CrossRefPubMedCentral

Genovesi S, Vincenti A, Rossi E, Pogliani D, Acquistapace I, Stella A, Valsecchi MG (2008) Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients. Am J Kidney Dis 51:255–262CrossRef

Winkelmayer WC, Patrick AR, Liu J, Brookhart MA, Setoguchi S (2011) The increasing prevalence of atrial fibrillation among hemodialysis patients. J Am Soc Nephrol 22:349–357CrossRefPubMedCentral

Atar I, Konaş D, Açikel S, Külah E, Atar A, Bozbaş H, Gülmez O, Sezer S, Yildirir A, Ozdemir N, Müderrisoğlu H, Ozin B (2006) Frequency of atrial fibrillation and factors related to its development in dialysis patients. Int J Cardiol 106:47–51CrossRefPubMedCentral

Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, Akar JG, Badhwar V, Brugada J, Camm J, Chen PS, Chen SA, Chung MK, Nielsen JC, Curtis AB, Davies DW, Day JD, d'Avila A, de Groot NMSN, Di Biase L, Duytschaever M, Edgerton JR, Ellenbogen KA, Ellinor PT, Ernst S, Fenelon G, Gerstenfeld EP, Haines DE, Haissaguerre M, Helm RH, Hylek E, Jackman WM, Jalife J, Kalman JM, Kautzner J, Kottkamp H, Kuck KH, Kumagai K, Lee R, Lewalter T, Lindsay BD, Macle L, Mansour M, Marchlinski FE, Michaud GF, Nakagawa H, Natale A, Nattel S, Okumura K, Packer D, Pokushalov E, Reynolds MR, Sanders P, Scanavacca M, Schilling R, Tondo C, Tsao HM, Verma A, Wilber DJ, Yamane T (2017) 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary. J Arrhythm 33:369–409CrossRefPubMedCentral

Sairaku A, Yoshida Y, Kamiya H, Tatematsu Y, Nanasato M, Hirayama H, Nakano Y, Kihara Y (2012) Outcomes of ablation of paroxysmal atrial fibrillation in patients on chronic hemodialysis. J Cardiovasc Electrophysiol 23:1289–1294CrossRefPubMedCentral

Takigawa M, Kuwahara T, Takahashi A, Kobori A, Takahashi Y, Okubo K, Watari Y, Sugiyama T, Kimura S, Takagi K, Hikita H, Hirao K, Isobe M (2014) The impact of haemodialysis on the outcomes of catheter ablation in patients with paroxysmal atrial fibrillation. Europace 16:327–334CrossRef

Hayashi M, Kaneko S, Shimano M, Ohashi T, Kubota R, Takeshita K, Shinoda M, Inden Y, Kanayama H, Murohara T (2014) Efficacy and safety of radiofrequency catheter ablation for atrial fibrillation in chronic hemodialysis patients. Nephrol Dial Transplant 29:160–167CrossRefPubMedCentral

Kuck KH, Brugada J, Fürnkranz A, Metzner A, Ouyang F, Chun KR, Elvan A, Arentz T, Bestehorn K, Pocock SJ, Albenque JP, Tondo C, Investigators FIREANDICE (2016) Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med 374:2235–2245CrossRef

10.

Kato N, Nitta J, Sato A, Inamura Y, Takamiya T, Inaba O, Negi K, Takahashi Y, Goya M, Sasano T (2020) Characteristics of the nonpulmonary vein foci induced after second-generation cryoballoon ablation for paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 31:174–184CrossRef

11.

Kanda Y (2013) Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant 48:452–458CrossRef

12.

Tripepi G, Benedetto FA, Mallamaci F, Tripepi R, Malatino L, Zoccali C (2007) Left atrial volume monitoring and cardiovascular risk in patients with end-stage renal disease: a prospective cohort study. J Am Soc Nephrol 18:1316–1322CrossRef

13.

Iravanian S, Dudley SC Jr (2008) The renin-angiotensin-aldosterone system (RAAS) and cardiac arrhythmias. Heart Rhythm 5:S12–17CrossRefPubMedCentral

14.

Buiten MS, de Bie MK, Rotmans JI, Gabreëls BA, van Dorp W, Wolterbeek R, Trines SA, Schalij MJ, Jukema JW, Rabelink TJ, van Erven L (2014) The dialysis procedure as a trigger for atrial fibrillation: new insights in the development of atrial fibrillation in dialysis patients. Heart 100:685–690CrossRef

15.

Zaza A (2009) Serum potassium and arrhythmias. Europace 11:421–422CrossRef

16.

Metzner A, Reissmann B, Rausch P, Mathew S, Wohlmuth P, Tilz R, Rillig A, Lemes C, Deiss S, Heeger C, Kamioka M, Lin T, Ouyang F, Kuck KH, Wissner E (2014) One-year clinical outcome after pulmonary vein isolation using the second-generation 28-mm cryoballoon. Circ Arrhythm Electrophysiol 7:288–292CrossRef

17.

Fürnkranz A, Bordignon S, Dugo D, Perotta L, Gunawardene M, Schulte-Hahn B, Nowak B, Schmidt B, Chun JKR (2014) Improved 1-year clinical success rate of pulmonary vein isolation with the second-generation cryoballoon in patients with paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 25:840–844CrossRef

18.

Ciconte G, de Asmundis C, Sieira J, Conte G, Di Giovanni G, Mugnai G, Saitoh Y, Baltogiannis G, Irfan G, Coutiño-Moreno HE, Hunuk B, Velagić V, Brugada P, Chierchia GB (2015) Single 3-minute freeze for second-generation cryoballoon ablation: one-year follow-up after pulmonary vein isolation. Heart Rhythm 12:673–680CrossRef

19.

Miyazaki S, Hachiya H, Nakamura H, Taniguchi H, Takagi T, Hirao K, Iesaka Y (2016) Pulmonary vein isolation using a second-generation cryoballoon in patients with paroxysmal atrial fibrillation: one-year outcome using a single big-balloon 3-minute freeze technique. J Cardiovasc Electrophysiol 27:1375–1380CrossRef

20.

Aryana A, Singh SM, Kowalski M, Pujara DK, Cohen AI, Singh SK, Aleong RG, Banker RS, Fuenzalida CE, Prager NA, Bowers MR, D'Avila A, O'Neill PG (2015) Acute and long-term outcomes of catheter ablation of atrial fibrillation using the second-generation cryoballoon versus open-irrigated radiofrequency: a multicenter experience. J Cardiovasc Electrophysiol 26:832–839CrossRef

21.

Reddy VY, Sediva L, Petru J, Skoda J, Chovanec M, Chitovova Z, Di Stefano P, Rubin E, Dukkipati S, Neuzil P (2015) Durability of pulmonary vein isolation with cryoballoon ablation: results from the sustained PV isolation with arctic front advance (SUPIR) study. J Cardiovasc Electrophysiol 26:493–500CrossRef

22.

Aryana A, Singh SM, Mugnai G, de Asmundis C, Kowalski M, Pujara DK, Cohen AI, Singh SK, Fuenzalida CE, Prager N, Bowers MR, O'Neill PG, Brugada P, d'Avila A, Chierchia GB (2016) Pulmonary vein reconnection following catheter ablation of atrial fibrillation using the second-generation cryoballoon versus open-irrigated radiofrequency: results of a multicenter analysis. J Interv Card Electrophysiol 47:341–348CrossRef

23.

Kuck KH, Albenque JP, Chun KJ, Fürnkranz A, Busch M, Elvan A, Schlüter M, Braegelmann KM, Kueffer FJ, Hemingway L, Arentz T, Tondo C, Brugada J, FIRE AND ICE Investigators (2019) Repeat ablation for atrial fibrillation recurrence post cryoballoon or radiofrequency ablation in the FIRE AND ICE trial. Circ Arrhythm Electrophysiol 12:e007247

Title: Cryoballoon versus radiofrequency ablation for paroxysmal atrial fibrillation in hemodialysis patients
Authors: Tomomasa Takamiya
Junichi Nitta
Osamu Inaba
Akira Sato
Yukihiro Inamura
Nobutaka Kato
Kazuya Murata
Takashi Ikenouchi
Toshikazu Kono
Giichi Nitta
Yutaka Matsumura
Yoshihide Takahashi
Masahiko Goya
Tetsuo Sasano
Publication date: 01-12-2020
Publisher: Springer Japan
Keywords: Antiarrhythmic Drugs
Atrial Fibrillation
Published in: Heart and Vessels / Issue 12/2020
Print ISSN: 0910-8327
Electronic ISSN: 1615-2573
DOI: https://doi.org/10.1007/s00380-020-01646-5

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Cryoballoon versus radiofrequency ablation for paroxysmal atrial fibrillation in hemodialysis patients

Abstract

Introduction

Methods and results

Conclusion

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Introduction

Methods and results

Conclusion

Please log in to get access to this content

Other articles of this Issue 12/2020

TRPC6 participates in the development of blood pressure variability increase in sino-aortic denervated rats

Acknowledgement to reviewers

Risk factors for permanent pacemaker implantation in patients receiving a balloon-expandable transcatheter aortic valve prosthesis

Association of renal resistance index and arterial stiffness on clinical outcomes in patients with mild-to-moderate renal dysfunction and presence or absence of heart failure with preserved ejection fraction

Left ventricular contractile performance and heart failure in patients with left ventricular ejection fraction more than 40%

Histone methylation and demethylation are implicated in the transient and sustained activation of the interleukin-1β gene in murine macrophages

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page